scholarly journals NEPRHOGENIC ASCITES: A CASE OF POORLY UNSTATED SYNDROME

2021 ◽  
Vol 10 (4) ◽  
pp. 3401-3403
Author(s):  
Monali Rajendra kumar Sahu
Keyword(s):  
Chronic Disease ◽  
Renal Transplant ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Rare Entity ◽  
Peritoneal Membrane ◽  
Ultra Filtration ◽  
Stage Renal Disease ◽  
End Stage ◽  
First Time

Nephrogenic ascites is a controversial and very rare entity; it was described for the first time in 1970.It is often described as an antites of ascites in patients undergoing renal transplant therapy with end-stage renal disease (ESRD). This condition is thought to be multifactorial in origin resulting from including amalgamation of malnutrition, inadequate dialysis and ultra-filtration with resultant uraemia and increased peritoneal membrane permeability. Prognosis is often grave particularly if timely diagnosis is not done with ensuing treatment. We are talking about the story of a 40-year-old man with no medical history who once reported to us the discomfort, nausea and vomiting that lasted for two days. He was found to have multiple ascites. A diagnostic paracentesis was performed and it was revealed that the patient had Hepatic, cardiovascular, infectious and dangerous causes of ascites were not excluded after a thorough examination. The cause of ascites was determined to be phrogenic. Patient showed excellent renal recovery and disappearance of ascites which makes this case quite unusual given the setting of absence of chronic disease of kidney as well as liver.

Is Hepatitis C More Aggressive in Renal Transplant Patients Than in Patients With End-Stage Renal Disease?

2006 ◽  
Vol 40 (5) ◽  
pp. 444-448 ◽  
Author(s):  
Renata M. Perez ◽  
Adalgisa S. P. Ferreira ◽  
Jos?? O. Medina-Pestana ◽  
Miguel Cendoroglo-Neto ◽  
Valeria P. Lanzoni ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Renal Transplant ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Transplant Patients ◽  
Renal Transplant Patients ◽  
Stage Renal Disease ◽  
End Stage

Pharmacokinetics of Intravenous and Intraperitoneal Cefotaxime in Patients Undergoing CAPD

1985 ◽  
Vol 5 (1) ◽  
pp. 33-35 ◽  
Author(s):  
Karel Matousovic ◽  
Josef Moravek Stefan ◽  
Vitko Vladimir Prat ◽  
Milena Horcickova
Keyword(s):  
Renal Function ◽  
Renal Insufficiency ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Peritoneal Membrane ◽  
Severe Renal Insufficiency ◽  
Elimination Half ◽  
Stage Renal Disease ◽  
End Stage ◽  
Dialysis Solutions

We investigated the pharmacokinetics of non-metabolized cefotaxime in 10 patients undergoing CAPD. The elimination half-life after IV administration of I g cefotaxime was 3.1 ± 1.3 hr, i.e. two to three times longer than in individuals with normal renal function but similar to patients with severe renal insufficiency. An average of 2.18% of the dose was recovered in the effluent. The halflife of I g cefotaxime administered in the dialysis solutions was 1.4 ± 0.8 hr. This difference between the half-lives after intraperitoneal and intravenous administration indicates a faster transport through the peritoneal membrane. Intraperitoneally administered cefotaxime -250 mg four times daily, was effective in the treatment of peritonitis in three CAPD patients. Since its introduction in 1976, CAPD has become an effective therapy for end-stage renal disease. The most serious complication is peritonitis and effective treatment is essential. Cefotaxime, a new broad-spectrurn cephalosporin, is active against most gramnegative and gram-positive organisms. It possesses no nephrotoxicity and may be useful in the treatment of peritonitis and other infections in patients on CAPD. This study was done to evaluate the pharmacokinetics of cefotaxime administered intravenously and intraperitoneally during CAPD.

A185 Effectiveness of bariatric surgery in end-stage renal disease requiring dialysis to increase renal transplant eligibility

2019 ◽  
Vol 15 (10) ◽  
pp. S56-S58
Author(s):  
Basem Soliman ◽  
Nabil Tariq ◽  
Dan Mija ◽  
Nwabunie Nwana ◽  
Rita Bosetti ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Renal Transplant ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Association of microsatellite markers on chromosomes 6q27 region and 10p15 region with end-stage renal disease in a UK renal transplant population

2009 ◽  
Vol 54 (8) ◽  
pp. 497-498 ◽  
Author(s):  
Diane Currie ◽  
Amy Jayne McKnight ◽  
Christopher C Patterson ◽  
Rosalind J L Martin ◽  
Derek Middleton ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Renal Disease ◽  
Microsatellite Markers ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Renal transplant improves pulmonary hypertension in patients with end stage renal disease

2011 ◽  
Vol 6 (3) ◽  
pp. 155 ◽  
Author(s):  
Serife Bozbas ◽  
Suleyman Kanyilmaz ◽  
Sule Akcay ◽  
Huseyin Bozbas ◽  
Cihan Altin ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Renal Transplant ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document